If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
327.00    8.40 (2.64%)
Bid:
326.80
Ask:
327.60
Spread: 0.80 (0.245%)
Market Cap: £716.36m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

$500m complex strategies investment fund close

3 Jul 2017 07:00

RNS Number : 8170J
Burford Capital
03 July 2017
 

This announcement contains inside information.

 

3 July 2017

 

BURFORD CAPITAL CLOSES $500 MILLION COMPLEX STRATEGIES INVESTMENT FUND

 

Burford Capital Limited ("Burford"), a leading global finance firm focused on law, announces that on 30 June 2017 its affiliate Burford Capital Investment Management LLC closed a new $500 million fund to invest in litigation-related complex strategies.

 

The new fund will invest in assets that Burford believes are mispriced and where value can be realized through recourse to litigation and regulatory processes. As such, Burford, through this new fund, generally will act as a principal as opposed to financier. The fund has already invested more than $100 million contemporaneous with its closing. Burford regards its investment strategies as proprietary and will not release information about its underlying investment strategies.

 

Burford will rely on its existing team of litigation and financial talent in connection with its investing activities in the new fund. It also has expanded the team by hiring a dedicated portfolio manager, Matthew Schoenfeld. Mr. Schoenfeld was most recently with Driehaus Capital and Morgan Stanley's Special Situations Group and is a graduate of Columbia University and Harvard Law School.

 

The new fund is structured as an evergreen fund with a perpetual life based on continued LP commitments. Investors in the fund will pay Burford a management fee of 2% per annum on drawn capital and a performance fee of 20% of fund profits on each resolved investment, subject to a 5% per annum priority return to investors, after which the Burford performance fee will receive a traditional general partner catch-up.

 

Burford is enthusiastic about the opportunities in litigation-related complex strategies, and is attracted to a greater level of exposure to those investments than it would achieve simply through performance fee income. As a result, Burford has committed $150 million to the new fund from its own balance sheet (a commitment on which it will not pay fees). Burford's employees and directors are similarly positive and have personally invested more than $5 million in the new fund. Thus, the amount raised from third-party investors on which fees will be paid is nearly $350 million.

 

Adam Gerchen, Burford's President who will oversee the activities of the new fund, said:

"We are delighted to broaden Burford's investment activities with this new fund. Institutional investor demand for allocations to the new fund was robust, and we are grateful for the support we received. With Burford's co-investment, we believe that the alignment of interests will well serve both Burford's shareholders and the fund's investors. We are excited about the opportunities to expand Burford's business that have presented themselves since the combination of Burford and Gerchen Keller."

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Elizabeth O'Connell, Managing Director.

 

For further information, please contact:

 

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

Nicholas Harland

Liberum Capital Limited - Joint Broker

+44 (0)20 3100 2222

Richard Crawley

Jamie Richards

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

Andrew Holloway

Neustria Partners - Financial Communications for Burford Capital

+44 (0)20 3021 2580

Robert Bailhache [email]

Charles Gorman [email]

Nick Henderson [email]

Burford Capital Limited

+1 212 235 6825

Elizabeth O'Connell, CFA, Managing Director

 

 

 

About Burford Capital

Burford Capital is a leading global finance firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London and Chicago.

 

For more information about Burford, visit www.burfordcapital.com

 

 

Important Information

Burford Capital Investment Management LLC ("BCIM") is registered as an investment adviser with the U.S. Securities and Exchange Commission. This release is for informational purposes only. It describes multiple investment vehicles that total $500 million in size, are focused on a single investment strategy, and share common terms such as management and performance fees. Nothing herein should be construed as a solicitation to offer investment advice or services. Information about investing in BCIM-managed funds is available only in the form of private placement memoranda and other offering documents.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUURANRBWANOAR
Date   Source Headline
2nd Jul 202611:00 amRNSIssue of Equity in Connection with LTIP
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.